Cardio-oncology & otherCohort study

Prevalence, patterns and outcomes of cardiac involvement in Erdheim–Chester disease

Eur Heart JPublished

  • Retrospective cohort study
  • single-centre
  • French tertiary center

Authors' conclusion

Cardiac involvement is present in nearly half of ECD patients and is associated with BRAFV600E mutation and complications (pericarditis, cardiac tamponade, and conduction disorders) but not with lower survival.

Study context

Population
Patients with Erdheim-Chester disease (ECD) who underwent cardiac magnetic resonance (CMR), French tertiary center, 2003–2019
Participants
200 patients
Exposure
Cardiac involvement in ECD and its association with mutation status, clinical events and survival
Outcome
All-cause mortality
Follow-up
Median 5.5 years (3.3-9 years)

Main finding

All-cause mortality by cardiac involvement

Adjusted hazard ratio

1.4

95% CI 0.8–2.5

P = 0.2

Cardiac involvement
adjusted HR 1.4 (95% CI 0.8–2.5); P = 0.2

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

Association of cardiac involvement with BRAFV600E mutation and ECD-related clinical events

ComparisonOR (95% CI)P value
Cardiac involvement · BRAFV600E mutation7.4 (3.5–16.8)P < 0.001
Cardiac involvement · ECD-related clinical events5 (1.5–21.2)P = 0.004

Cardiac involvement (prevalence)

Cardiac involvement
96 patients (48%)

CMR findings

Right atrioventricular sulcus infiltration
37%
Pericardial effusion
24%

Pericarditis, cardiac tamponade, conduction disorders, coronary artery disease (CAD)

patients

Pericarditis (7 acute, 1 constrictive)
8 (4%)
Cardiac tamponade
10 (5%)
ECD-related high-degree conduction disorders
5 (2.5%)
CAD
45 (23%)

Original publication

Prevalence, patterns and outcomes of cardiac involvement in Erdheim–Chester disease. Eur Heart J. Published 21 December 2022. doi:10.1093/eurheartj/ehac741

Summarised from the published abstract; every number is checked against it